Genomic DNA is extracted from dried blood spots (DBS) of the newborns and analyzed to detect, by real time PCR with a probe targeting the c.840C nucleotide in SMN1, absence/conversion of the SMN1 exon 7, which represents the molecular cause of SMA in over 95% of cases. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.